Julian Peto Selected Research

Julian Peto Research Topics

Disease

59	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2002
38	Neoplasms (Cancer) 01/2022 - 03/2004
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2012 - 08/2002
4	Mesothelioma 12/2018 - 01/2009
3	Papillomavirus Infections 01/2019 - 04/2003
3	Lung Neoplasms (Lung Cancer) 12/2018 - 03/2016
3	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 10/2015
3	Familial Breast Cancer 11/2017 - 03/2008
2	Disease Progression 01/2020 - 02/2008
2	Genetic Risk Score 01/2020 - 05/2015
2	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 12/2017
2	Colorectal Neoplasms (Colorectal Cancer) 11/2016 - 06/2009
2	Uterine Cervical Dysplasia 11/2012 - 07/2009
2	Malignant Mesothelioma 08/2011 - 10/2009
1	COVID-19 06/2020
1	Triple Negative Breast Neoplasms 01/2019
1	Chromosome Fragility 01/2019
1	Pneumothorax 12/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Endometriosis 01/2018
1	Sclerosis 12/2017
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2016
1	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Hypersensitivity (Allergy) 12/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2013
1	Inflammation (Inflammations) 03/2012
1	Coronary Disease (Coronary Heart Disease) 03/2012

Drug/Important Bio-Agent (IBA)

31	Estrogen ReceptorsIBA 01/2022 - 07/2005
14	Hormones (Hormone)IBA 01/2021 - 08/2009
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 05/2009
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2004
6	ORALIT (ORS)IBA 01/2021 - 03/2008
6	Biological ProductsIBA 01/2018 - 05/2002
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
4	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 11/2015
4	AsbestosIBA 12/2018 - 01/2009
4	3' Untranslated Regions (3' UTR)IBA 11/2016 - 01/2014
4	Oral ContraceptivesIBA 01/2013 - 08/2002
3	human ERBB2 proteinIBA 01/2022 - 12/2011
3	RNA (Ribonucleic Acid)IBA 06/2020 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 04/2013
3	MicroRNAs (MicroRNA)IBA 11/2016 - 01/2014
3	Cytochrome P-450 CYP3AIBA 03/2016 - 05/2012
3	Estrone FDA Link 03/2016 - 05/2012
3	Messenger RNA (mRNA)IBA 01/2016 - 04/2009
3	Estrogens (Estrogen)FDA Link 10/2015 - 05/2009
2	ElementsIBA 01/2021 - 04/2009
2	Amphibole AsbestosIBA 12/2018 - 05/2016
2	GlucuronidesIBA 03/2016 - 05/2014
2	ChromatinIBA 01/2016 - 01/2015
2	LuciferasesIBA 07/2015 - 04/2013
2	VaccinesIBA 11/2012 - 06/2011
2	Epidermal Growth Factor (EGF)IBA 04/2012 - 10/2011
2	Genetic Markers (Genetic Marker)IBA 06/2009 - 03/2008
2	Contraceptive Agents (Contraceptives)IBA 11/2007 - 04/2003
2	Carrier Proteins (Binding Protein)IBA 03/2006 - 01/2005
2	Insulin-Like Growth Factor I (IGF-1)IBA 03/2006 - 01/2005
1	Progesterone FDA LinkGeneric 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	A-Form DNA (A-DNA)IBA 01/2019
1	diepoxybutaneIBA 01/2019
1	olaparibIBA 01/2019
1	Serpentine Asbestos (Chrysotile)IBA 12/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2017
1	HLA-DPB1 antigen (HLA DPB1)IBA 12/2017
1	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Amosite Asbestos (Amosite)IBA 05/2016
1	EnzymesIBA 03/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2016
1	Pharmaceutical PreparationsIBA 03/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Death Domain ReceptorsIBA 01/2016
1	erioniteIBA 01/2016
1	BRCA1 ProteinIBA 01/2016
1	Mineral Fibers (Mineral Fiber)IBA 01/2016
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 07/2015
1	Hepatocyte Nuclear Factor 1IBA 03/2015
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2015
1	PhosphofructokinasesIBA 04/2014
1	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2013
1	Deoxyribonucleases (DNase)FDA Link 12/2013
1	Cyclin D1IBA 04/2013
1	mahuang-tangIBA 04/2013
1	CarcinogensIBA 06/2012
1	SteroidsIBA 05/2012

Therapy/Procedure

5	Therapeutics 04/2013 - 12/2006
2	Radiotherapy 01/2019 - 03/2004
2	Pneumonectomy (Lung Volume Reduction) 08/2011 - 10/2009
1	Transjugular Intrahepatic Portasystemic Shunt 12/2018
1	Drug Therapy (Chemotherapy) 03/2016
1	Secondary Prevention 11/2012
1	Conservative Treatment 11/2012
1	Aftercare (After-Treatment) 11/2012